Safety and Efficacy Assessments of Osalmid in Multiple Myeloma

NCT03670173 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Osalmid

Sponsor

Shanghai 10th People's Hospital

Collaborators

[object Object]